Industry
Benjamin Hadida discusses how to validate innovative clinical trial design and overcome challenges of robust-large scale manufacturing.
Rebyota Approved for the Prevention of Recurrence of Clostridioides difficile Infection in Adults
The discovery contributes to the understanding of the infant gut microbiome and how it evolves during development.
This strategic partnership is set to accelerate the international distribution of Microba’s microbiome testing into primary and specialist healthcare, and move our testing deeper into routine patient management.
Yvonne Nyavor discusses the improvement of analysis methods for Live Biotherapeutics Products.
Important goal reached by the Novara-based pharmaceuticals company, specialised in the production and marketing of live biotherapeutic products.
Formal approval of BiomeBank’s first-generation donor derived microbiome-based therapy product, BIOMICTRA registered in the Australian Register of Therapeutic Goods
Healthy, diabetic, and obese people compared on diet and lifestyle using innovative technologies and multi-omics analysis
Servatus are hopeful this study will eventuate into real benefits to sufferers of rheumatoid arthritis
René Kamminga, CEO of OptiBiotix: “OptiXOS is unlike any prebiotic fibre commercially available in Europe today".
